SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0000950123-00-002110
Filing Date
2000-03-09
Accepted
2000-03-09 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM F-1 F-1/A 297175
  Complete submission text file 0000950123-00-002110.txt   298609
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA, H4M 2V2 A8
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT, QUEBEC CANADA H4M 2V2 A8 514-332-3222
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-31310 | Film No.: 564508
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1